Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Additive Beneficial Effect of Zolpidem Onto the Antidepressant Therapy in Depressive and Dysthimic Patients in the Acute Phase of the Disease

NCT00292734 is registered in ClinicalTrials.gov with Sanofi as lead sponsor.

NCT NCT00292734
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00292734 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Additive Beneficial Effect of Zolpidem Onto the Antidepressant Therapy in Depressive and Dysthimic Patients in the Acute Phase of the Disease
Lead sponsor
Sanofi
Phase
Phase 4
Overall status
Completed
Start date
January 31, 2005
Completion date
June 30, 2006
Enrollment
120
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

depression, sleep initiation and maintenance disorders